Golden Reign Resources (GRR-V) appoints Dr. Rael Lipson to board
Oct 16, 2013 - News Release
Dr. Lipson, BSc (honours), MSc geology, PhD geochemistry, has over 40 years of global experience in the mining industry. He is a graduate of the University of Witwatersrand and earned his PhD from the University of Cape Town.Dr. Lipson was the chief geologist for Gold Fields Exploration Inc., a part of Gold Fields Ltd., and recently left the organization after 36 years. Gold Fields is one of the world's leading gold producers with nine operating mines in Australia, Ghana, Peru and South Africa. Dr. Lipson strengthened Gold Fields competitive position by assessing the geological potential of gold projects around the world. Guiding the strategic direction for exploration investments, he targeted projects ranging from greenfields to producing mines through joint venture opportunities or acquisitions. Additionally, Dr. Lipson pioneered the development of a knowledge-based software solution, Global Business Area Rating System (GBAR), to identify the most gold-prospective areas on the globe based on geological criteria but balanced by sovereign risk.
A natural leader, Dr. Lipson strongly believes in coaching and mentoring the next generation of Earth scientists. An active member of the Society of Economic Geologists (SEG) since 1992, Dr. Lipson mentors in economic geology. Dr. Lipson is well versed with Golden Reign's Nicaraguan projects, having visited the company's flagship San Albino-Murra gold property on two previous occasions.
Kim Evans, president and chief executive officer, commented: "I am extremely pleased and honoured to have Rael join our board of directors. He is a highly experienced and accomplished geologist, a strategic thinker, and a thoughtful, insightful individual. Rael has a hands-on, pro-active approach that, coupled with his strong technical abilities, will no doubt make him an excellent addition to Golden Reign's team."
The company has granted, pursuant to its stock option plan and subject to regulatory approval, an initial 60,000 options to a director at an exercise price of 25 cents per share for a term of five years. The securities represented by this grant will be subject to a four-month hold period. |
